Embody vs Oak Longevity: Low-Price GLP-1 Options Compared
Quick verdict: For the lowest advertised entry price choose Embody; for one-price-for-all-dosages and included coaching choose Oak Longevity. This Embody vs Oak Longevity comparison looks only at the supplied facts to help cost or feature focused patients decide.
See Embody pricing and options
Pricing and billing: headline differences
Embody advertises compounded semaglutide at $69/month and compounded tirzepatide at $119/month, with a note that the $69 semaglutide price is a limited-time offer. Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month and states one flat price covers all dosages. Oak bills monthly on a non-recurring basis and three-month prescriptions are billed upfront; Embody promotes a flat locked monthly price and no long-term membership.
Medication format and regulatory notes
Both providers offer compounded semaglutide and compounded tirzepatide. Each source includes the regulatory caution that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness, or quality. Embody explicitly contrasts compounded options with branded products by noting it does not offer branded Ozempic, Wegovy, or Zepbound.
Shipping speed, access, and approvals
Embody promises free shipping with delivery in 1–2 days after clinician approval. Oak Longevity offers free shipping with tracking and notes most patients receive medication within a few days; Oak also advertises same-day approval for qualifying patients. Both operate via online clinician review and do not require insurance.
Clinical review, coaching, and eligibility
Oak Longevity highlights free health coaching included with every plan and board certified physicians in your state reviewing cases; Oak also specifies patients with BMI below 20 do not qualify for GLP-1 treatment and notes not appropriate for patients under 18, pregnant, or nursing. Embody describes licensed provider review handled entirely online and includes telemed visits with prescription; Embody emphasizes a lean program with fewer premium features and no integrated coaching as a trade off for lower price.
Side note on commitments and cancellations
Embody markets no monthly membership and cancel anytime flexibility. Oak notes no subscriptions or membership fees and that three-month prescriptions are billed upfront with no refunds available after physician approval and once medication has shipped.
| Criteria | Embody | Oak Longevity |
|---|---|---|
| Semaglutide starting price | $69/month (compounded) | $133/month (compounded) |
| Tirzepatide starting price | $119/month (compounded) | $199/month (compounded) |
| Dosage pricing model | Price may vary by dose; $69 is entry price | One price covers all dosages |
| Shipping speed | Free shipping, arrives in 1–2 days after approval | Free shipping with tracking; most receive within a few days; same-day approval available |
| Coaching and extras | No integrated coaching; lean program | Free health coaching included |
| Billing and membership | No monthly membership; cancel anytime | No subscription; billed monthly non-recurring; three-month options billed upfront |
| Regulatory note | Compounded medications not FDA approved | Compounded medications not FDA approved |
How the differences matter
Price sensitive patients who prioritize the lowest possible monthly cash price are reflected by Embody’s $69 semaglutide entry price and $119 tirzepatide price. Patients who prefer predictable one-price dosing and included coaching will find Oak Longevity’s one-price-for-all-dosages and free health coaching aligned with their needs. Shipping speed favors Embody on its explicit 1–2 day delivery claim, while Oak highlights same-day approval availability for qualifying patients.
Summary table takeaways
Embody vs Oak Longevity centers on three main trade offs supported by the sources: entry price, coaching and extras, and pricing model. Embody’s clear strength in the supplied facts is its advertised low entry price and rapid shipping after approval. Oak Longevity’s supplied strengths are one-price-per-dosage model, included coaching, and non-recurring billing options with same-day approval for some patients.
Conclusion: Choose based on priorities
Embody vs Oak Longevity is ultimately a choice between lowest advertised entry price plus fast shipping (Embody) and a one-price dosing model with free coaching and non-recurring billing (Oak Longevity). Both offer compounded semaglutide and tirzepatide and both note compounded medications are not FDA approved.
Choose Embody if you want the lowest advertised starting price and fast 1–2 day shipping after clinician approval. Choose Oak Longevity if you prefer one flat price for all dosages and included health coaching with non-recurring billing.